What is the appropriate valacyclovir dosage for an otherwise healthy adult with recurrent herpes labialis (cold sore)?

Valacyclovir Dosing for Cold Sores

For an otherwise healthy adult with a cold sore, take valacyclovir 2 grams twice daily for 1 day (two doses separated by 12 hours), starting at the very first symptom such as tingling, itching, or burning. 1

Episodic Treatment Regimen

• The FDA-approved dose is valacyclovir 2 g twice daily for 1 day, with doses taken exactly 12 hours apart. 1
• This single-day, high-dose regimen reduces the median episode duration by approximately 1.0 day compared to placebo and is supported by high-quality evidence. 2, 3
• The regimen shortens healing time, decreases pain, and accelerates lesion resolution. 4, 3

Critical Timing for Maximum Efficacy

• Initiate therapy during the prodromal phase (tingling, burning, itching) or within the first 24 hours of lesion onset to achieve optimal benefit, because peak viral titers occur in the first 24 hours after lesions appear. 2, 1
• Starting treatment after 24 hours markedly reduces efficacy and prolongs episode duration. 2
• When started during prodrome, valacyclovir may prevent lesion development entirely in approximately 42–47% of patients. 2, 5

Alternative Episodic Regimens

• Famciclovir 1500 mg as a single oral dose is an equally effective alternative with convenient one-time dosing. 2
• Acyclovir 400 mg orally five times daily for 5 days remains effective but requires more frequent dosing, which may reduce adherence. 2

Suppressive Therapy for Frequent Recurrences

• For patients with ≥6 cold sore episodes per year, the CDC recommends daily suppressive therapy with valacyclovir 500 mg once daily (can increase to 1000 mg once daily for very frequent recurrences). 2
• Daily suppressive therapy reduces recurrence frequency by ≥75% and significantly prolongs the time to first recurrence. 2, 6
• Valacyclovir has documented safety for 1 year of continuous use; after 1 year, consider a trial off therapy to reassess recurrence frequency. 2

Renal Dose Adjustments

• In patients with creatinine clearance 30–49 mL/min: reduce to 1 gram every 24 hours (do not exceed 1 day of treatment). 1
• In patients with creatinine clearance 10–29 mL/min: reduce to 500 mg every 24 hours. 1
• In patients with creatinine clearance <10 mL/min: reduce to 500 mg every 24 hours. 1
• In elderly patients (≥80 years), assess renal function before initiating therapy to avoid drug accumulation and neurotoxicity. 2

Safety and Tolerability

• Valacyclovir is generally well-tolerated with minimal adverse events in immunocompetent adults. 2, 4
• Common side effects include headache (<10%), nausea (<4%), and diarrhea, which are typically mild to moderate in intensity. 2, 4
• Serious adverse events are rare in otherwise healthy adults. 4

Contagiousness and Transmission Counseling

• Patients remain contagious until all lesions are fully crusted, which is the standard clinical endpoint indicating substantial reduction in transmission risk. 2
• Valacyclovir shortens viral shedding from lesions by approximately 21% (mean 6.4 days with valacyclovir versus 8.1 days with placebo). 2
• Advise patients to avoid direct skin-to-skin contact (kissing) and sharing items that contact the mouth (towels, utensils, lip balm) until all lesions are completely crusted. 2

Common Pitfalls to Avoid

• Do not rely on topical antivirals as primary treatment; oral therapy is markedly superior in reducing episode duration and pain. 2
• Do not delay treatment initiation; efficacy decreases significantly when therapy starts after the first 24 hours or after lesions have fully developed. 2
• Do not use inadequate dosing; the short-course, high-dose regimen (2 g twice daily for 1 day) is more effective than traditional longer courses at lower doses. 2

Special Populations

• Immunocompromised patients may require higher doses or longer treatment durations and have a higher acyclovir resistance rate (7% versus <0.5% in immunocompetent hosts). 2
• For confirmed acyclovir-resistant HSV, switch to foscarnet 40 mg/kg IV three times daily. 2

Preventive Measures

• Counsel patients to apply sunscreen (SPF ≥15) or zinc oxide to lips before UV exposure to prevent UV-triggered recurrences. 2, 7
• Advise patients to identify and avoid personal triggers including fever, psychological stress, and menstruation. 2